SINOHEALTH HOLDINGS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.36 HKD | -.--% |
|
-0.37% | -3.42% |
| 04-24 | Sinohealth Holdings Profit Nearly Doubles in 2023 | MT |
| 03-28 | Sinohealth Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 25 September 2024 | CI |
| Sales 2024 * | 461M 63.68M 498M 5.11B | Sales 2025 * | 525M 72.52M 567M 5.82B | Capitalization | 2.06B 284M 2.22B 22.81B |
|---|---|---|---|---|---|
| Net income 2024 * | 89M 12.29M 96.17M 986M | Net income 2025 * | 109M 15.06M 118M 1.21B | EV / Sales 2024 * | 4.46 x |
| Net cash position 2024 * | - 0 0 0 | Net cash position 2025 * | - 0 0 0 | EV / Sales 2025 * | 3.92 x |
| P/E ratio 2024 * |
23.6
x | P/E ratio 2025 * |
19.1
x | Employees | 759 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 10.79% |
More Fundamentals
* Assessed data
More news
| 1 week | -0.37% | ||
| Current month | -1.65% | ||
| 1 month | -1.65% | ||
| 3 months | -8.38% | ||
| 6 months | +20.45% | ||
| Current year | -3.42% |
1 week
5.36
5.38
1 month
5.355.45
Current year
5.006.00
1 year
3.506.00
3 years
2.007.11
5 years
2.007.11
10 years
2.007.11
| Managers | Title | Age | Since |
|---|---|---|---|
Yu Shu Wu
CEO | Chief Executive Officer | 48 | 30/11/07 |
Xu Hui Yi
DFI | Director of Finance/CFO | 51 | 29/02/20 |
Ke Ke Tang
CTO | Chief Tech/Sci/R&D Officer | 37 | 31/03/17 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Dan Zhou Wang
BRD | Director/Board Member | 60 | 30/09/17 |
Bin Wei
BRD | Director/Board Member | 53 | - |
Yu Shu Wu
CEO | Chief Executive Officer | 48 | 30/11/07 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/04/24 | 5.36 | -.--% | 500 |
| 29/04/24 | 5.36 | -0.19% | 0 |
| 26/04/24 | 5.37 | +0.19% | 4,000 |
| 25/04/24 | 5.36 | -0.37% | 0 |
| 24/04/24 | 5.38 | -0.37% | 0 |
Delayed Quote Hong Kong S.E., April 30, 2024 at 09:08 am
More quotes
Sinohealth Holdings Ltd is a China-based investment holding company. The Company primarily provides data insight solutions, data-driven publications and events and software as a service (SaaS) products. Data insight solutions include growth and investment decision solutions and data-driven marketing solutions. Data-driven publications and events include combination of publications, precision connections and exhibition services. SaaS products include Smart Decision Cloud, Smart Retail Cloud, Smart Health Management Cloud and Smart Medical Cloud. The Company mainly operates its businesses in the domestic and overseas markets.
Sector
Business Support Services
Calendar
25/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
1
Last Close Price
4.96
CNY
Average target price
3.879
CNY
Spread / Average Target
-21.80%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -3.42% | 284M | |
| +10.11% | 66.8B | |
| +10.32% | 18.03B | |
| +19.90% | 13.3B | |
| +6.70% | 13.08B | |
| +15.17% | 9.98B | |
| -35.27% | 5.55B | |
| -11.50% | 5.54B | |
| -3.72% | 4.9B | |
| -5.77% | 4.71B |
- Stock Market
- Equities
- 2361 Stock
